Ahead of his presentation at Connect to Frankfurt (opened September 28th), EPM spoke exclusively with Heiko Schmidt, Strategy & Consulting Life Sciences lead, Accenture AG, about why CDMOs should be prepared to track sustainability metrics now and how companies which wait now, will likely be forced to catch-up at higher costs. He also looks at why sustainability matters and what can CDMOs expect in contracts and regulatory requirements in the next 5 years.
Key insights:
- Sustainability metrics could become mandatory for investment opportunities, as many investors are emphasising that sustainability will be added to the decision criterium.
- Pharma companies which wait now to implement initiatives for sustainability will likely be forced later by regulation to catch-up quick at even higher costs.
- CDMOs tracking their sustainability metrics requires knowing which metrics should be reported, how to track those and which levels of metrics aggregation are desired by their customers.
Connect to Frankfurt is a new digital platform specifically designed for CPHI attendees to get the most out of their CPHI Frankfurt experience – even before they attend – it presents more than 30 on-demand webinars, and offers a head start on networking, meetings, and understanding the very latest in pharma industry developments.